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The enzymes involved in cellular bioenergetics comprise an intricate series of 
electron receptors which act together to produce the electrochemical energy necessary to 
drive proton translocation and ultimately, ATP synthesis. In mammalian cells, at least five 
complexes are operant with two mobile electron carriers (ubiquinone and cytochrome c). 
Each enzyme complex contains many subunits and each subunit can facilitate any of a host 
of functions ranging from maintaining structure to participation in the ligation of specific 
prosthetic groups directly involved in electron transport. 
Because of the complexity of eukaryotic systems, a clearer understanding of 
protein function and architecture can often be elucidated when prokaryotic systems are 
examined. For example, while beef heart cytochrome c oxidase (complex IV) contains 13 
subunits, cytochromes bo3 and bd oxidase from Escherichia coli, which are both 
analogous to the mammalian complex IV, contain only 4 and 2 subunits respectively. 
Since the ultimate function of both systems is the same (i.e. energy production) it is easy 
to see how investigation of simpler systems leads to important insights about more 
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complicated systems. However, even though the simplicity oflower organisms sometimes 
makes them a better choice for study, a complete understanding of bioenergetics requires 
concurrent study of more complex cells. 
There are several reasons which make prokaryotic organisms experimentally 
advantageous over eukaryotic equivalents. Foremost is the relative biological simplicity of 
prokaryotes compared to eukaryotes. As stated above, many bacterial enzymes 
accomplish the same reactions as their eukaryotic counterparts with a much simpler 
design. While many eukaryotic enzyme complexes contain supernumerary subunits with 
unknown functions, prokaryotic complexes typically only contain subunits which are 
involved in substrate binding or contain catalytic prosthetic groups. Many times, the 
catalytic subunits of prokaryotic enzyme complexes correspond to the mitochondrial 
encoded subunits of the eukaryotic systems, indicating they may share an early 
evolutionary history. This makes the prokaryotes ideal for structural and functional 
studies aimed at the mechanism of the catalytic core. Furthermore, many prokaryotic 
enzymes are easily expressed in recombinant cells. Thus, site-directed mutagenesis has 
become particularly valuable in determining information about the structure of these 
prokaryotic enzyme complexes. 
Of considerable interest in the investigation of these enzymes are substrate and 
inhibitor binding sites. Although a compound may have been known to act as a natural 
substrate for years, many times even the general location of binding is unknown. The 
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same is true for inhibitors. Both the site and mechanism of binding are important for drug 
therapy, and by studying these sites, and the interaction of the substrate or inhibitor with 
the enzyme complex, a better understanding of the mechanism of electron transport can be 
acquired. Furthermore, studies of substrate and inhibitor binding can give important clues 
as to the three dimensional structure or subunit relationships of the complexes. 
In this thesis, enzymes from both prokaryotic (E. coli) and eukaryotic (bovine 
heart mitochondria) sources which are well characterized electron transport complexes are 
investigated. In Chapter II, "Identification of the Ubiquinol-Binding Site in the 
Cytochrome bo3 -Ubiquinol Oxidase of Escherichia coli," we use a substrate analog of 
one of the terminal oxidases of E. coli, cytochrome bo3, to identify the most likely subunit 
involved in substrate binding. Similar approaches have been used to identify the binding 
sites of the other E. coli oxidase, cytochrome bd, as well as some eukaryotic enzymes. 
In Chapter III, "The Effects of Nitric Oxide on Electron Transport Complexes," a 
general approach to investigate how nitric oxide inhibits electron transport complexes was 
taken by monitoring activity loss due to nitric oxide treatment, and changes in EPR 
spectrum. Because the EPR spectra of the bovine complexes II and III are well 
characterized, beef heart mitochondria was the major source of enzyme for the study. 
However, we were also interested in comparing the effects of a eukaryotic system with 
those of a prokaryotic system, so complex II was also purified from E. coli and the effects 
of nitric oxide were described for this enzyme as well. 
In order to describe the significance of these studies, and to help understand why 
they were initiated, a brief review of the mammalian complexes of electron transport (I-
IV) and their prokaryotic equivalents is provided. Complex Vis the ATP synthase and is 
not directly involved in electron transport. Its function is to couple electron transport to 
ATP synthesis via the proton motive force generated by the previous four complexes. 
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Mitochondrial complex I (NADH-ubiquinone oxidoreductase), consisting of 41 or 
more polypeptides (1), is the most intricate complex, and probably the least understood. 
An intrinsic protein of the mitochondrial inner membrane, it serves as the entry point of 
NA.DH into the electron transport chain by catalyzing the reversible oxidation of NA.DH 
to NAD+ coupled to the reduction of ubiquinone to ubiquinol. This reaction results in the 
translocation of 4 protons across the inner membrane per electron pair transferred from 
NA.DH to Q (2-4). The genetic origin of the subunits of complex I are both mitochondrial 
and nuclear ( 5-7). In respiratory bacteria, complex I contains a minimal amount of 
subunits. These include all subunits coded for by mitochondrial genes and homologues of 
subunits with prosthetic groups or substrate binding sites (5-7). 
Complex II (succinate-Q reductase) not only functions as an enzyme of electron 
transport but is also involved in the tricarboxylic acid cycle, where it is responsible for the 
oxidation of succinate to fumarate. Complex II from mitochondria (8) contains both a 
water soluble succinate dehydrogenase and a membrane anchoring protein which aids in its 
function. The first component, succinate dehydrogenase, is composed of two protein 
subunits. Fp is the larger of the two and contains a covalently linked FAD. The smaller 
one ( designated Ip, or iron containing protein) contains three iron-sulfur clusters. The 
second component of complex II is the membrane anchoring protein fraction. Depending 
on the source of the complex, 2-3 subunits have been isolated. These proteins are 
generally referred to as QPs, cytochrome b56o, or hydrophobic protein fractions (9). 
Complex II has beeri isolated from numerous eukaryotic and prokaryotic sources, 
and for the most part appears to be highly conserved (10, 11). This is especially true of 
both the Fp and Ip amino acid sequences. For example, in comparing Ip sequences from 
Escherichia coli and beef heart mitochondria, approximately 50% of the sequences are 
identical (12). However, in Bacillus subtilis, the function ofFp and Ip is carried out by a 
single transmembrane protein ( 13-15). 
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Complex III, also known as the be 1 complex, is a member of a larger superfamily 
of enzymes found in mitochondria, some Gram-positive bacteria, and chloroplasts (where 
they are know as bef complex) ( 16-21 ). Complex III is an integral membrane protein 
which spans either the mitochondrial inner membrane, bacterial plasma membrane, or the 
chloroplast thylakoid membrane. It catalyzes the two-electron oxidation ofubiquinol (or 
plastoquinol) with the concurrent one-electron reduction of cytochrome c ( or plastoquinol 
or c2). This reaction is coupled to generation of a proton gradient and membrane potential 
across the membrane for ATP synthesis. Three redox centers, a Rieske high potential 
[2Fe-2S] cluster (22) and cytochromes band c1, are essential for activity (23), but no 
additional redox prosthetic groups are known to exist in any of the bc1 complexes. 
Mitochondrial be 1 contains several supernumerary subunits which lack prosthetic groups 
(24, 25). 
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Complex IV is known to catalyze reduction of 0 2 to water and couples this 
reaction to proton-pumping. Four protons are translocated by cytochrome oxidase across 
the membrane per four electrons transferred from cytochrome c to 02 in intact 
mitochondria (matrix side to cytoplasmic side) (26, 27) and in artificial phospholipid 
vesicles (28). Beef heart Complex IV is composed of 13 subunits (29) and all have been 
sequenced. Mitochondrial genes code for the three largest subunits (subunits 1-111), but 
the rest are coded for by nuclear genes (30). Crystals of the complex have been made, and 
a three dimensional structure of the entire 13 subunit complex has been elucidated with a 
2.8 A resolution (31). 
Complex IV is a member of the heme-copper oxidase superfamily (32-34) which 
includes the mitochondrial cytochrome c oxidases as well as most of the prokaryotic 
respiratory oxidases. This superfamily divides into two major branches: the cytochrome c 
oxidases and the quinol oxidases. The three mitochondrial encoded subunits of the 
eukaryotic oxidases are found in most of the bacterial oxidases. However, all members of 
the oxidase superfamily contain a subunit homologous to subunit I, the largest subunit of 
the mammalian cytochrome c oxidase. This subunit contains two hemes and one copper 
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(CuB) prosthetic group. One of the hemes is six-coordinate, and the second is a 
component of the heme;.copper binuclear center, which is the site where di oxygen binds 
and is reduced to water. Based on studies of mitochondrial complex IV and oxidases from 
Rhodobacter sphaeroides and Paracoccus denitrificans only subunits I and II are required 
for proton pumping coupled to electron transfer (35, 36). 
The investigation of our first project involving cytochrome bo3 from E. coli began 
in examining the structural relationship between this enzyme and beef heart cytochrome 
oxidase. It appears that the major structural differences of subunits I, II, and III of 
cytochrome bo3 compared to cytochrome oxidase reside in subunit II. For example, 
subunit II of the cytochrome c oxidases, contains the immediate electron acceptor from 
cytochrome c, the CuA redox center. Furthermore, the cytochrome c binding site appears 
to be on subunit II of these oxidases. In the quinol oxidases, Cu A is not present, and the 
amino acid residues implicated in either the binding of cytochrome c or ligating to CuA are 
not conserved. Subunit II in E. coli, therefore, must have a function different than binding 
and reduction of cytochrome c. Since cytochrome bo3 was a quinol oxidase (not 
cytochrome c oxidase), it seemed plausible that if subunit II had an analogous function in 
E. coli to the mitochondrial enzyme, subunit II would be the site of quinol binding. This 
in part warranted the investigation on our part to examine the quinol binding site of 
cytochrome bo 3 from E. coli. We therefore made determining the quinol binding site the 
major objective of the first part of this work. From this study, it appears that ubiquinol-8 
specifically interacts with subunit II of cytochrome bo3 (37). 
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As stated previously, inhibitors of electron transport can be important tools in 
investigating the mechanism of electron transport. This has been particularly true in the 
elucidation of the widely accepted Q cycle of complex III. The Q cycle is a complicated 
mechanism which describes the nonlinear transfer of electrons from ubiqµinol to 
cytochrome c through the bc1 complex (38-41). Briefly, the Q cycle can be broken down 
into two tightly coupled steps. In the first half, a sequence of electron transfer events 
transfers one electron from ubiquinol to cytochrome c and two protons are released to the 
outer side of the membrane. This generates one ubisemiquinone and one reduced 
cytochrome c. The ubiserniquinone generated is on the outer side of the membrane. It 
passes its electron to cytochromes bL and bH which then reduces a different ubiquinone on 
the inner side of the membrane to a ubisemiquinone. In the second half of the cycle, the 
same initial events reduce another cytochrome c and produce another ubisemiquinone on 
the outer side of the membrane. This time, however, the electrons from cytochrome hu 
along with two protons from the inner side of the membrane reduce a ubisemiquinone 
from the inner side of the membrane (previously reduced by the first half of the cycle) to 
ubiquinol. In this way, two cytochrome c molecules are reduced per one ubiquinol 
oxidized to ubiquinone while four protons are deposited on the outer side of the 
membrane and two protons consumed on the inner side of the membrane. 
Antimycin A inhibits the Q cycle at the step where cytochrome h reduces ubiquinol 
and causes electrons to accumulate in the h cytochromes and in ubiquinol ( 42). This 
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specific inhibitor has been instrumental in the elucidation of the Q cycle. The oxidant-
induced reduction of cytochrome b in slow respiring mitochondria is increased by addition 
of antimycin A (for a review see 43). However, the oxygen burst also causes increased 
oxidation of cytochromes c and c1. These observations which cannot be explained by a 
linear electron transport pathway are consistent with the Q cycle. 
Recently nitric oxide has been shown to be an inhibitor of electron transport. 
Specifically, three mitochondrial enzymes have been shown to be inhibited by macrophage 
derived nitric oxide ( 44-46). They are mitochondrial aconitase, complex I, and complex 
II. Although the interaction appears to be less specific than that of other inhibitors such as 
Antimycin A, a precise mechanism of inhibition may be operant. Presumably, nitric oxide 
reacts with the iron sulfur clusters of the mitochondrial complexes. Each of the enzymes 
or complexes mentioned above are known to contain iron sulfur clusters of the [4Fe - 4S] 
type. 
Moreover, unlike Antimycin A, and most other inhibitors of electron transport, 
nitric oxide occurs naturally in the cell. In mammalian cells, nitric oxide is synthesized 
from L-arginine by an endogenous biosynthetic pathway ( 4 7-51) catalyzed by nitric oxide 
synthase. Several types of cells contain nitric oxide synthase, including endothelial cells 
(52, 53), macrophages (54, 55), neutrophils (56), and cerebellar neurons (57). It is in the 
macrophages and neutrophils that the action of nitric oxide is cytotoxic. These cells 
release nitric oxide on surrounding cells targeted for destruction by the immune response. 
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Cell death is thought to occur by the inhibition of electron transport. However, the 
extreme reactivity of nitric oxide makes the precise mode of action difficult to investigate 
as nitric oxide also reacts with numerous other cellular components as well. But these 
effects are not clearly defined in vivo. 
If the interaction of nitric oxide with either aconitase, complex I, or complex II 
could be more completely understood, nitric oxide could become important in their further 
characterization. A specific inconsistency concerning the effects of nitric oxide on these 
enzymes that requires attention has to due with nitric oxide's effect on the iron sulfur 
clusters of these enzymes. If nitric oxide was specific for iron sulfur clusters, why were 
the effects of nitric oxide on complex III not significant? As described above, complex III 
contains an iron sulfur cluster of the Rieske type which is essential to activity of the 
complex. However, when the effects of mitochondrial enzymes were monitored after 
treatment with macrophage induced nitric oxide, only aconitase and complexes I and II 
were markedly inhibited. This observation brought about the question of how nitric oxide 
reacted with the iron sulfur clusters. Do different types of clusters react to nitric oxide 
differently? And are other iron sulfur clusters nitric oxide resistant? 
Since inhibitors have been so effective in elucidating complicated mechanisms of 
electron transport, especially in complex III, investigation of the effects of nitric oxide on 
this complex and others appeared to be merited. Of specific interest was comparing the 
effects of nitric oxide on complex II to any effects on complex III. Furthermore, if nitric 
oxide effected different iron sulfur clusters in different manners, or if the effects of nitric 
oxide were specific for only certain types of clusters, enzymes from different sources but 
with the same types of clusters should be effected by nitric oxide in similar manners. 
These questions formed the basis for the objectives set forth in the second half of this 
work. Therefore, to test these hypotheses, the effects of nitric oxide on complexes I and 
II from beef heart mitochondria and complex II from Escherichia coli were monitored. 
The results reported in this thesis show that complex III can be inhibited by nitric 
oxide, but only when purified as a single complex. When copurified with complex II, 
complex III is not effectively inhibited by nitric oxide. It is not certain that this selective 
inhibition is due to a difference in iron sulfur cluster arrangement. Perhaps a more likely 
conclusion is that complex II protects complex III form the effects of nitric oxide when 
the two are copurified as a super complex (58). 
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Our studies on electron transport complexes which began as broad questions about 
the basic designs of these eukaryotic and prokaryotic systems have now been focused to 
specific investigations about substrate binding and inhibitor interactions, which have been 
completed. In the case of E. coli cytochrome ho3, the major objective was to identify the 
site of quinol binding. This was accomplished by determining a suitable substrate 
photoaffinity analog, establishing a clear correlation between the rates of photoinactivation 
and covalent attachment of the substrate to the enzyme, and showing that alternative 
substrates or competitive inhibitors reduce the rate of photoinactivation. 
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In studying the effects of nitric oxide on electron transport complexes, the primary 
objective was to define the effects of nitric oxide on SQR and QCR given their 
relationship in electron transport. This was accomplished by monitoring the effects of 
nitric oxide on SQR and QCR either as single enzyme complexes or copurified as SCR. 
The results of the effects of NO on mitochondrial SQR were compared with E. coli SQR. 
The results were determined by monitoring activity loss and changes in EPR spectra. 
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CHAPTER II 
IDENTIFICATION OF THE UBIQUINOL-BINDING SITE IN THE CYTOCHROME 
bo3-UBIQUINOL OXIDASE OF ESCHERICHIA COLI 
SUMMARY 
The cytochrome ba3-ubiquinol oxidase, one of two ubiquinol oxidases in 
Escherichia coli, is a member of the heme-copper oxidase superfamily. The enzyme 
contains four protein subunits (I-IV) with apparent molecular masses of 58, 33, 22, and 17 
kDa, respectively. Cytochrome bo3 catalyzes the 2-electron oxidation of ubiquinol and the 
reduction of molecular oxygen to water. Although the primary structures of all four 
subunits have been determined, the ubiquinol-binding site has not been investigated. The 
photoreactive radiolabeled azido-ubiquinone derivative 3-[3H]azido-2-methy-5-methoxy-
6-geranyl-l,4-benzoquinone (azido-Q), which has been widely used in locating the 
ubiquinone-binding sites of other enzymes, was used to identify the subunit(s) involved in 
the binding of quinol to cytochrome bo3. When reduced by dithioerythritol, the azido-Q 
derivative functioned as a substrate with partial effectiveness, suggesting that azido-Q 
interacts with a legitimate quinol-binding site. When cytochrome bo3 was 
incubated with an 8-fold molar excess of azido-Q, illumination by UV light for 10 min 
resulted in a 50% loss of activity. The uptake of radiolabeled azido-Q by the oxidase 
complex upon illumination correlated with the photoinactivation. In the presence of the 
competitive inhibitor 2-heptyl-4-hydroxyquinoline (HQNO) or ubiquinol, the rate of 
azido-Q uptake and loss of enzyme activity upon illumination decreased. Analysis of the 
distribution of radioactivity among the subunits after separation by SDS-polyacrylamide 
gel electrophoresis showed that subunit II was heavily labeled by azido-Q, but that the 
other subunits were not. This suggests that the ubiquinol-binding site of the cytochrome 




The cytochrome bo3-ubiquinol oxidase is one of two terminal ubiquinol oxidases in 
the aerobic respiratory system of Escherichia coli (59, 60). This relatively simple 
respiratory chain branches at the level ofubiquinol, which can be oxidized by either the 
cytochrome bo3 or cytochrome bd oxidase (59). While the cytochrome bos-ubiquinol 
oxidase has been shown to predominate under highly aerobic growth conditions, 
cytochrome bd predominates when oxygen is limited (61). Cytochrome bo-' catalyzes the 
2-electron oxidation of ubiquinol-8 within the cytoplasmic membrane and the 4-electron 
reduction of molecular oxygen to water (62, 63). In the cell, this reaction generates a 
transmembrane charge separation and is coupled to proton pumping, thus generating a 
proton-motive force (64). The formation of a proton electrochemical gradient has been 
demonstrated by reconstitution of the oxidase in artificial phospholipid vesicles (65-67). 
SDS-polyacrylamide gel electrophoresis analysis of the purified oxidase reveals 
four or five subunits, depending on the purification protocol employed (68, 69). The four-
subunit preparation of the enzyme, utilized in this work, contains subunits with apparent 
molecular masses of about 58, 33, 22, and 17 kDA for subunits I-IV respectively. All the 
of the subunits are encoded by the cyoABCDE operon. The genes encode subunits II 
(cyoA), I (cyoB), III (cyoC), and IV (cyoD). The fifth gene, cyo E, 
has been shown to be a farnesyl transferase, required for the biosynthesis of heme 0 
prosthetic group in the oxidase. 
Cytochrome bo3 is a member of the heme-copper oxidase superfamily (32-34). 
This superfamily includes most prokaryotic respiratory oxidases as well as the 
mitochondrial cytochrome c oxidases. All members of this oxidase superfamily contain a 
subunit homologous to the largest subunit of the mammalian cytochrome c oxidase 
(subunit I). This subunit contains two hemes and one copper (CuB) prosthetic group. 
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One of the hemes is six-coordinate, and the second is a component of the heme-copper 
binuclear center, which is the site where dioxygen binds and is reduced to water. In most 
cases, the bacterial oxidases contain homologues of the three mitochondrial encoded 
subunits of the eukaryotic oxidases (subunits I-III). For example, subunits I-III of 
cytochrome bo3 from E. coli are homologous to the corresponding subunits of the 
mitochondrial cytochrome c oxidases. However, subunit IV of the E. coli oxidase appears 
to be unrelated to any eukaryotic protein. 
There are two major branches of this superfamily: the cytochrome c oxidases and 
the quinol oxidases. The major structural differences appear to reside in subunit II. In the 
cytochrome c oxidases, for example, subunit II contains the CuA redox center, which is the 
immediate electron acceptor from cytochrome c. Subunit II also appears to be the site 
where cytochrome c binds to these oxidases. In the quinol oxidases, CuA is not present, 
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and the amino acid residues implicated in either the binding of cytochrome c or ligating to 
CuA are not conserved. 
Little information concerning the quinol-binding site is available. A labeled 
substrate analogue that could be covalently attached to the binding site was synthesized to 
locate the subunit(s) that presumably compose the quinol-binding site. This analogue is a 
photoreactive radiolabeled azido-ubiquinone derivative, specifically 3-[3H]azido-2-methyl-
5-methoxy-6-geranyl-l,4-benzoquirtone (azido-Q) (70). The success of azido-Q in the 
identification of quinone-binding subunits has been demonstrated in cytochrome bd 
oxidase from E. coli and ubiquinol-cytochrome c reductases from various sources (70-72). 
A similar technique has also been successfully employed to identify the quinone-binding 
subunit in NADH-ubiquinone reductase (73, 74). The results reported herein indicate that 
the quinol-binding site of cytochrome bo3-ubiquinol oxidase is on subunit II. When 2,3-
dimethoxy-5-methyl-6-ethyl-1,4-benzoquinone (QoC2) was incubated along with azido-Q, 
the rates of activity loss and azido-Q uptake were decreased. The presence of 2-heptyl-4-
hydroxyquinoline (HQNO), an inhibitor of cytochrome bo3-ubiquinol oxidase, in the 
incubation system also resulted in a decrease in azido-Q uptake upon illumination. These 
results suggest that there is some competition for the binding site between the substrate 
analogues and azido-Q and between HQNO and azido-Q. 
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EXPERIMENTAL PROCEDURES 
Materials-Cytochrome ba3-ubiquinol oxidase was prepared by a reported 
procedure (69) and stored in 50 rnM potassium phosphate buffer, pH 8.1, with either 
Triton X-100 or Sarkosyl detergents. Neither of these detergents was suitable for azido-Q 
labeling experimentation. Since Triton X-100 and Sarkosyl interfered with the labeling 
study, these detergents were exchanged for I% cholate by the following procedures. The 
enzyme was precipitated by 50% ammonium sulfate and then dissolved in 50 rnM 
sodium/potassium phosphate buffer, pH 7.8, containing I% sodium cholate and 10% 
glycerol. Alternately, the oxidase was treated with BIO-BEAD and then solubilized in 
buffer containing I% sodium cholate. The cholate-solubilized quinol oxidase was stored at 
-20 °C until use. 
The concentrations of the oxidase ( 69), ubiquinol-1, and azido-Q were determined 
spectrophotometrically. Quinone concentrations were measured in 95% ethanol at a Amax 
of276 nm for ubiquinol-1 and 291 nm for azido-Q using an extinction coefficient of 12.25 
x 103 cm-1 mor1 liter for both. 
Azido-Q (10,000 cpm 3H/nmol), 2,3-dimethoxy-5-methyl-1,4-benzoquinone (Q0), 
2,3-dimethoxy-5-methyl-6-isoprenyl-1,4-benzoquinone (Q 1), 2,3-dimethoxy-5-methyl-6-
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geranyl-1, 4-benzoquinone, 2,3-dimethoxy-5, 6-dimethyl- l, 4-benzoquinone ( QoC 1), 2,3-
dimethoxy-5-methyl-6-ethyl- l, 4-benzoquinone (QoC2), 2,3-dimethoxy-5-methyl-6-butyl-
l, 4-benzoquinone ( Q0C4), 2,3-dimethoxy-5-methyl-6-pentyl- l, 4-benzoquinone ( QoC s ), 
2,3-dimethoxy-5-methyl-6-heptyl-1,4-benzoquinone (QoC1), and 2,3 dimethoxy-5-methyl-
6-nonyl-1,4-benzoquinone (Q0C9) were synthesized by reported methods (75, 76). The 
synthesis of azido-Q is outlined in Scheme I-(a) and quinone structures are shown in 
Scheme I-(b ). Dithioerythritol and cholic acid were purchased from Sigma; Tween 20 and 
electrophoresis reagents were purchased from Bio-Rad. All other chemicals and reagents 
were of the highest purity available. 
Assay Conditions-Quinol oxidase activity was assayed spectrophotometrically and 
polarographically. Ten microliters of pure cytochrome bo3-ubiquinol oxidase (0.5 mg/ml) 
in 50 mM sodium/potassium phosphate buffer, pH 7. 8, containing O. 1 % sodium cholate 
was used. The assay mixture for the spectrophotometric assay contained 50 mM 
potassium phosphate, pH 7.4, 0.025% Tween 20, and 25 µM substrate. Oxidation of 
ubiquinol was followed by an increase in absorbance at 280 nm with an extinction 
coefficient of 12.25 x 103 cm·1 mol" 1 liter (70). 
In some experiments, activity was measured by following 0 2 uptake at 25 °C using 
a Yellow Springs Model 53 oxygen monitor. For these measurements, the assay mixture 
contained 50 mM potassium phosphate buffer, pH 7.4, 0.06% Tween 20, and 2 mM 
dithioerythritol. Quinol concentrations ranging from 3 to 16. 7 ~tM were used as 
Scheme 1-(a): Synthesis of 3-[3H]azido-2-methyl-5-methoxy-6-geranyl-
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Photoinactivation-Scheme II outlines the photoinactivation and subunit labeling 
procedure. The enzyme (40 µMin 50 mM sodium/potassium phosphate buffer, pH 7.8. 
containing 0.5% sodium cholate) was incubated with radiolabeled azido-Q (8-fold molar 
excess) and subjected to UV illumination (70). The stock solution of azido-Q was 5 mM 
in ethanol. In some experiments, an additional quinone derivative or inhibitor was included 
in the solution. The enzyme solution was placed into a 2-mm light path cuvette. This was 
incubated in ice water in a container with a quartz window. For the time course study of 
both inactivation and azido-Q uptake upon illumination, aliquots of enzyme sample were 
withdrawn from the illuminated cuvette at various time intervals. One portion was used to 
determine the enzyme activity, and the other was used to measure uptake of azido-Q by 
the protein. Ten microliters of the illuminated samples was withdrawn at various time 
intervals and spotted onto a piece ofWhatman No. 3MM filter paper (15 x 15 cm) 0.5 
inch from the bottom. The paper was kept in the dark. Once all the samples were 
spotted, the paper was then developed with a 2: I chloroform/methanol solution and air-
dried. The spots, which retained the protein at their original positions, were cut into small 
pieces. They were then placed into 7-ml scintillation vials with 6 ml of Packard Insta-Gel 
XF, and their radioactivity was determined. Radioactivity was measured in a Packard 
1900CA liquid scintillation analyzer. 
Scheme II: Subunit Labeling Procedure Using Azido-Q 
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Scheme II: Subunit Labeling Procedure Using Azido-Q (cont.) 
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Determination of the Distribution of 3H Radioactivity Among the Subunits of the 
Enzyme Complex-After 10 min of UV illumination, 1-1.5 mg of protein was spotted 
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onto filter paper, and unbound quinone was eluted as described above. The strip 
containing the protein was then cut into small pieces and incubated in 400 µI of 20 mM 
Tris-CI, pH 7.8, containing 1% SDS and 1% 2-mercaptoethanol for -40 hours. The 
subunits were separated by electrophoresis on a 15% polyacrylamide gel run at 200 V for 
50 min. Before addition of the sample, glycerol was added to the digestion buffer to a 
final concentration of 12%, and fluorescamine was also added. After running, the gel 
(viewed under UV irradiation) was cut into strips, and the band pattern as seen by 
fluorescamine was recorded. For each experiment, one lane of standard and one lane of 
sample were reserved for staining with Coomassie Blue as previously described (77). The 
strips were placed into preweighed test tubes so that the weights of the gel strips could be 
determined. To each tube was added 2 ml of 3 N ammonium hydroxide, and the strips 
were broken into small pieces. The tubes were sealed and incubated at· 110 °C for 6 hours. 
The contents of each tube were then placed into 20-ml scintillation vials with 18 ml of the 
mixture, and radioactivity was counted. Since the presence of gel causes a significant 
amount of quenching, a correction of this quenching in the counting system must be made. 
A given amount of radioactive azido-Q was mixed with a given amount of gel solution 
before polymerization and subjected to the same treatment as that of gel strips of the 
samples. The ratio of radioactivities determined in the presence of gel was used as a factor 
for the correction of the quenching. 
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RESULTS 
Effect of Varying the Ouinone Side Chain on Cytochrome borUbiquinol Oxidase 
Activity-The natural substrate of cytochrome bo3-ubiquinol oxidase is ubiquinol-8. This 
quinone has a carbon side chain consisting of eight isoprenoid units or a total of 40 
carbons. The low solubility ofubiquinol-8 in aqueous solution makes it less attractive to 
use as a substrate in routine assays. Lower quinol homologues are generally used in the 
determination of oxidase activity. Ubiquinol-1 (Q1H2), which contains only one 
isoprenoid unit, is the most commonly used substrate for cytochrome bo3-ubiquinol 
oxidase. It is of interest to investigate the substrate.specificity of other low homologues of 
synthetic ubiquinones. Fig. 1 summarizes the effects of different quinone derivatives on 
oxidase activity. The quinone derivatives examined contain unbranched saturated side 
chains that vary only in the length of their carbon side chains (denoted QoCn). The activity 
of the oxidase was followed both spectrophotometrically and polarographically. 
In polarographic assays, the quinones were maintained reduced by dithioerythritol, 
and oxygen uptake was measured directly with an oxygen electrode. Considering the 
ubiquinol-1 activity to be I 00%, the activity with the other quinone derivatives is 
expressed as a percentage of ubiquinol-1 activity under the same experimental conditions 
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Fig. 1. Effectiveness of ubiguinone analogues as substrates of the cytochrome bo3 
complex. Q1H2 activity (29.1 µmo! of o~ min-1 mg- 1) was taken to be 100%. 
The darker bars represent the oxygen uptake measurements, while the lighter 
bars show the spectrophotometric assay results . The graph shows an average 
of five values obtained for each substrate. The quinone derivatives used were 
QoC1 , QoC2, QoC3, QoC4, QoCs , QoC1, QoC9, and QoC10. 
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Q0C1 and Q0C2 appear to be even better substrates than Q1H2, but Qo is inactive as a 
substrate for the cytochrome bo3 complex. 
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The surprisingly low rate of activity observed polarographically with QoC9 is due 
to the slow rereduction rate of Q0C9 by dithioerythritol under the assay conditions. This 
was experimentally verified by directly observing the rate of reduction 
spectrophotometrically. The slow rereduction rate of Q0C9 by dithioerythritol may be due 
to the more hydrophobic side chain of Q0C9, which could hinder its association with 
dithioerythritol. This was partially overcome by increasing the detergent concentration in 
the assay, resulting in an increase in oxidase activity specifically with QoC9, but not ,vith 
the other analogues, which are less hydrophobic and more water-soluble. In contrast, 
using the spectrophotometric assay, analogues with a side chain longer than that of 
ubiquinol-1 were shown to have activity comparable to that of ubiquinol-1. In this assay, 
all the substrates were reduced prior to the start of the assay. 
Oxidase Activity of Cytochrome ho3 Using Reduced Azido-0 as a Substrate-The 
azido-Q synthesized and used in this experiment has a 10-carbon side chain. To determine 
the feasibility of utilizing this azido-Q derivative as a probe of the quinol-binding site, the 
substrate activity of azido-Q was compared with that of ubiquinol-1. Using the 
polarographic assay, the specific activity using azido-Q is 11 % of that observed with 
ubiquinol-1, which is comparable to the results obtained with Q0C9 . The specific activity 
of QoC9 increases to 135% of that ofubiquinol-l when the spectroscopic assay is 
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employed but the comparable experiment with azido-Q could not be performed due to the 
chemical reactivity of the azido group of azido-Q. It is reasonable to conclude, however, 
that azido-Q is as effective a substrate as Q0C9 and therefore a reasonable substrate 
analogue. 
Correlation Between Inactivation of Oxidase Activity and Azido-0 Uptake Upon 
lllumination-As demonstrated in Fig. 2 the rate ofubiquinol-1 oxidation by the purified 
cytochrome bo3 complex decreases rapidly during the ~rst 10 min of illumination. in the 
presence of azido-Q to 50% of the original activity. Beyond 10 min, very little 
inactivation is observed, similar to the behavior when the oxidase is subjected to UV 
irradiation in the absence of azido-Q (Fig. 2). The incomplete ( 50%) photoinactivation of 
the cytochrome bo3 complex in the presence of azido-Q is comparable with results 
obtained previously with other membrane protein complexes using similar derivatives (70, 
71). The incomplete inactivation may be due to the presence of some of the endogenous 
quinone substrate present in the enzyme preparations. Fig. 2 also shows the rate of 
incorporation of the azido-Q label into the protein as a function of the time of irradiation. 
The label is covalently attached to the protein over the first 10 min of irradiation and 
parallels the observed inactivation of the oxidase (Fig. 2). It is reasonable to conclude that 
the inactivation during the first 10 min of illumination is due mostly to specific covalent 
linkage of azido-Q at the substrate-binding site, while the incorporation 
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Fig. 2. Correlation of photoinactivation of and azido-0 uptake by pure cytochrome ho 3 
oxidase treated with radiolabeled azido-0. The enzyme ( 41 ~tM cytochrome b 
in 50 mM sodium/potassium phosphate buffer, pH 7.8, containing 0.5% 
sodium cholate) was incubated with 320 µM radiolabeled azido-Q (8-fold 
molar excess) and subjected to illumination at O °C. For the time course study 
of inactivation and azido-Q incorporation upon UV irradiation, a given 
amount of the sample was withdrawn from the illuminated cuvette at various 
time intervals. One portion was used for the activity assay, and the other 
portion was used for determining the uptake. Activity was assayed 
spectrophotometrically in 50 mM potassium phosphate buffer pH 7.4 
containing 0.025% Tween 20. Oxidation of Q1H2 was followed at 280 nm. 
e, activity remaining after photoinactivation; •, uptake of azido-Q; A, 
control that contained no azido-Q. 
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of azido-Q after that is due to nonspecific interaction. 
Distribution of Radioactivity Among the Subunits of Cytochrome ho_,-Fig. 3 shmvs 
an SDS-polyacrylamide gel electrophoresis analysis of the oxidase after the protein had 
been subjected to the treatment designed to remove noncovalently bound azido-Q. 
Subunits I-III are apparent, and their relative intensities are comparable to those observed 
prior to irradiation. Subunit IV is difficult to detect, as is often the case. Also apparent is 
a small amount of a high molecular mass aggregate that is not due to the irradiation or 
labeling procedure, but is present in the gel pattern of the protein prior to treatment. Fig. 
3 demonstrates that the subunits are recovered after irradiation and the organic extraction 
treatment. Hence, the possibility that the more hydrophobic subunits might aggregate and 
not be recovered for this analysis can be excluded. 
Fig. 4 shows the distribution of radioactivity among the subunits of the 
cytochrome complex after 10 min of illumination. After photoinactivation of the enzyme, 
unbound azido-Q was removed, and the remaining sample was used for SDS-
polyacrylamide gel electrophoresis as described under "Experimental Procedures." After 
viewing the band pattern as labeled by fluorescamine, the gel was cut into slices, which 
were used to evaluate the distribution of (H]azido-Q by scintillation counting. The 
results are shown in Fig. 4 and clearly indicate that subunit II is preferentially labeled with 
azido-Q. Some azido-Q is also covalently linked to subunit III, but very little label is 
observed on subunit I. Although a role for subunit III in quinone binding certainly 
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Fig. 3. SDS-polyacrylamide gel electrophoresis pattern of cytochrome ho_,-ubiquinol 
oxidase. After elution of unbound quinone, the sample was incubated in 20 
mM Tris-Cl, pH 7.8, containing 1 % SDS, 1 % 2-mercaptoethanol, and 
12% glycerol and then applied to a 15% polyacrylamide gel run at 200V for 50 
min. Ten to fifteen micrograms of protein solution was loaded onto the sample 
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Fig. 4. Distribution of radioactivity among the subunits of the cytochrome bo3 
complex. Unbound azido-Q was removed from the treated cytochrome 
complex after 10 min of illumination. The remaining protein was then 
digested and subjected to SDS-polyacrylamide gel electrophoresis analysis. 
After electrophoresis, the gel pattern was recorded. A portion of the gel was 
saved for staining, while the rest of the gel was cut into slices for 
determination of radioactive incorporation. The positions of the four subunits 
of the cytochrome complex are indicated. 
cannot be excluded, it is worth noting that the high hydrophobicity of subunit Ill favors 
nonspecific interactions. The relative hydrophobicities of the first three subunits 
calculated from their amino acid compositions are 54, 46, and 66% for subunits I-III, 
respectively. (Relative hydrophobicity was calculated by considering Pro, Ala, Val Met, 
Ile, Leu, and Phe as hydrophobic amino acids). 
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A quantitative analysis indicates that 33% of the counts applied to the SOS gel are 
recovered. This loss is presumably due to the quenching effects of the gel. Of these 
counts, about half are associated with the polypeptides (shown in Fig. 4), whereas the 
remainder are residual label bound to phospholipids or in noncovalently bound form. The 
amount of azido-Q bound to total protein after electrophoresis was calculated to be O. 3 0 
mo! of quinone/mol of oxidase. 
Competitive Effects ofHQNO and OoCr To further strengthen the argument that 
azido-Q labeled an authentic quinol binding site on the enzyme, the effects of both HQNO 
and Q0C2 were investigated. HQNO is an effective inhibitor of the quinol oxidase and is 
thought to be a competitive inhibitor of quinol. Q0C2, as shown in Fig. 1, is an effective 
substrate of the oxidase. Fig. 5 shows the effects of varying concentrations of HQNO on 
the ubiquinol-1 oxidase activity of cytochrome ho 3. Under the conditions of the assay, the 
maximal inhibition is 82%, and no additional effect is observed beyond -25 ~tM. Fig. 6 
shows the effect of the presence of HQNO and Q0C2 on the rate of photoinactivation of 
the oxidase by azido-Q. Both compounds cause a reduced rate of inactivation of the 
oxidase. As observed in Fig. 6, the inactivation due to HQNO and that due to azido-Q 
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Fig 5. Inhibition of the cytochrome bo3 complex by HONO. Pure cytochrome bo3-
ubiquinol oxidase (0.6 mg/ml in 50 mM K2HP04 containing 0.1 % Triton X-
100, pH 8.1) was used for assay in 5-µl amounts. The assay mixture was 1 ml 
of 50 mM potassium phosphate buffer, pH 7.4, containing 0.025% Tween 20, 
and 50 nmol ofubiquinol-1 was used as substrate. Oxidation of Q1H2 was 
followed by absorption at 280 nm. HQNO was 10 mM in ethanol, and the 
amount in the assay mixture was varied from 5 to 50 nmol of total 
HQNO present. 
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appear to be additive. The extent of inactivation at 20 min is clearly not affected by the 
presence of Q0C2. This is probably due to the fact that the binding of QoC2 is reversible, 
whereas the photoinactivation is not reversible. On the other hand, HQNO does affect the 
extent of inactivation at all time observed. In these experiments, the amount ofHQNO 
used was adjusted to that sufficient to result in 50% inhibition in the presence of azido-Q. 
As noted in Fig. 6, inhibition due to HQNO in the presence of azido-Q without 
illumination is also observed, suggesting that HQNO binding to the oxidase is stronger 
than that of azido-Q. The inhibitory effect is thus not eliminated by either azido-Q or by 
other substrates under the given conditions. Fig. 7 shows the effects of both HQNO and 
Q0C2 on the incorporation of azido-Q into the oxidase. These data mimic those in Fig. 6 
in that both compounds slow the rate of incorporation into the oxidase. The presence of 
HQNO significantly decreases the noncovalent uptake of azido-Q by oxidase. Since 
inactivation by azido-Q is irreversible, whereas HQNO is a reversible inhibitor, complete 
blocking of the incorporation of azido-Q into the oxidase by HQNO is not expected. 
These data are consistent with the conclusion that azido-Q is binding to a specific 
quinol-binding site in cytochrome bo3 and that the observed results are not due to 
nonspecific binding to the oxidase. As expected, both the competitive inhibitor, HQNO, 
and the alternative substrate, QoC2, reduce the rate of photoinactivation by azido-Q. If 
azido-Q showed no preference for the binding site, one would expect the effects ofHQNO 
or QoC2 to be minimized. However, since results reported in this work show HQNO as a 
competitive inhibitor and QoC2 a suitable substrate, they must both interact with the quinol 
37 
100 
~ 0 .. 
C) 80 
C 
C ·-(U 60 E 
G) 
a: 




0 4 8 12 16 20 
Illumination Time, min 
Fig. 6. Effect ofHONO and 00C2 on the photoinactivation of cytochrome bo,-
ubiguinol oxidase. Cytochrome borubiquinol oxidase (40 µM cytochrome b 
in 50 mM sodium/potassium phosphate buffer, pH 7.8, containing 0.5% 
sodium cholate)was subjected to UV illumination at O °C as described under 
"Experimental Procedures." The sample was incubated with azido-Q (e), 
azido-Q and Q0C2 (.._), or azido-Q and HQNO (•). All substrates were 
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Fig 7. Effect ofHONO and OQC~ on azido-0 uptake by the cytochrome complex. The 
same sample as in Fig. 6 was treated in the same manner as described, except 
that radioactivity was measured. Plotted is the sample when incubated with 
azido-Q (e), azido-Q and Q0C2 (A), or azido-Q and HQNO (•). Again, all 
substrates were added to a final concentration of 320 µM total quinone 
present 
binding site. They therefore must interfere with azido-Q binding by preventing its ability 




The results of the experiments reported in this work clearly point to subunit II as 
being intimately involved in the quinol-binding site of the cytochrome bo3-ubiquinol 
oxidase from E. coli. This conclusion is supported by 1) the fact that the photoreactive 
label is itself a substrate for the enzyme; 2) the correlation between the rates of 
photoinactivation and of covalent attachment to the oxidase; and 3) the influence of an 
alternative substrate (Q0C2) and a competitive inhibitor (HQNO) on reducing the rate of 
photoinactivation of the oxidase by azido-Q. 
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Furthermore, the selective labeling of subunit II rules out nonspecific hydrophobic 
interactions as the major contributor to the labeling pattern since subunit II is the least 
hydrophobic of the subunits. This subunit appears to contain two transmembrane helical 
spans and a large hydrophilic carboxyl-terminal domain (78). It is the hydrophilic domain 
in the homologous subunit of the cytochrome c oxidases that contains the cytochrome c-
binding site (34) and that contains the CuA redox center (79). Hence, the results presented 
in this report indicate that the function of subunit II in both the cytochrome c oxidases and 
the quinol oxidases may be similar. In both cases, the subunit appears to be directly 
involved in binding to the substrate to be oxidized, either cytochrome c or ubiquinol. 
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It must be pointed out that these data by no means exclude other subunits from 
being directly involved in forming the quinol-binding site. Furthermore, the recent 
suggestion (80) that there could be two different quinol-binding sites within cytochrome 
bo3 needs to be investigated, and the use of the azido-Q label might prove useful to define 
such sites, if this proves to be the case. Clearly, the identification of the specific site 
labeled within subunit II under the present conditions will be the first priority, and such 
experiments are currently in progress. 
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CHAPTER III 
THE EFFECTS OF NITRIC OXIDE ON ELECTRON TRANSPORT COMPLEXES 
SUMMARY 
The effect of nitric oxide on mitochondrial electron transfer complexes was studied 
by comparing the activities of nitric oxide treated and untreated, deoxygenated samples of 
purified beef heart succinate-cytochrome c reductase, succinate-ubiquinone reductase, and 
ubiquinol-cytochrome c reductase. More than 90% of succinate-cytochrome c reductase 
activity is lost during nitric oxide treatment. The activity of the succinate-ubiquinone 
reductase component of succinate-cytochrome c reductase decreases 95%, while the 
ubiquinol-cytochrome c reductase component is unaffected by nitric oxide. This 
inactivation is due primarily to the destruction of iron sulfur clusters from succinate-
ubiquinone reductase. When purified beef heart succinate-ubiquinone reductase was 
treated with nitric oxide, virtually all activity was irreversibly lost. The EPR spectra of the 
treated complex showed typical iron-nitric oxide complex signals, confirming that 
inactivation is due to destruction of the iron-sulfur clusters. Similar results were obtained 
with purified E. coli succinate-ubiquinone reductase. Pure beef heart ubiquinol-
cytochrome c reductase treated with nitric oxide loses 40% of its initial 
4~ _, 
activity, but regains most of it (90-100%) after 24 hours of incubation at O °C in the 
absence of nitric oxide. This suggests that ubiquinol-cytochrome c reductase is protected 
from nitric oxide when complexed with succinate-ubquinone reductase or that when split 
from succinate-ubiquinone reductase, ubiquinol-cytochrome c reductase undergoes a 
conformational change which allows access of nitric oxide to the Rieske iron-sulfur center. 
Such access is not possible when ubiquinol-cytochrome c reductase is complexed with 
succinate-ubiquinone reductase. The loss of ubiquinol-cytochrome c reductase activity 
correlates with a decrease in the Rieske protein EPR signal intensity without formation of 
any new EPR signal. The Rieske iron-sulfur cluster signal is recovered after 24 hours 
incubation in the absence of nitric oxide. 
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INTRODUCTION 
Nitric Oxide (NO) is a small diatomic free radical, and a gas at room temperature. 
It is slightly soluble in water (2mM at 1 atm, 20 °C) and highly reactive. It reacts with 
molecular oxygen to yield nitrogen dioxide, a brown gas (81-83). NO also reacts with the 
superoxide anion 0 2- to form peroxonitrite (ONOO) (83). Other properties of NO include 
a remarkable ability to coordinate transition metal ions such as iron (Fe 2+ and Fe 3~), 
manganese, and copper. Many of these complexes have been well characterized, and 
several, including complexes formed when NO coordinates iron sulfur centers, can be 
detected by EPR spectroscopy (82). 
In mammalian cells, NO is synthesized from L-arginine by an endogenous 
biosynthetic pathway (47-51) catalyzed by NO synthase. Biosynthesis of NO occurs in 
many types of cells including endothelial cells (52, 53), macrophages (54, 55), neutrophils 
(56), and cerebellar neurons (57). The high reactivity of NO accounts for its involvement 
in diverse physiological functions. Three mitochondrial enzymes have been shown to be 
inhibited by macrophage derived NO (44-46). They are mitochondrial aconitase, NADH-
ubiquinone (Q) reductase ( complex I) and succinate ubiquinone reductase ( complex II or 
SQR). Each of these enzymes or complexes are known to contain iron sulfur clusters of 
the [4Fe - 4S] type. Complexes I and II in murine tumor cells are inhibited by direct 
exposure of the cells to NO gas (53, 84). This inhibition appears to result from NO 
interaction with the iron sulfur clusters of these enzymes. 
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Succinate-Q reductase (8) has two major components: a water soluble succinate 
dehydrogenase and a membrane anchoring protein. Succinate dehydrogenase is composed 
of two protein subunits. The larger one (Fp) houses a covalently linked FAD and the 
smaller one (Ip) binds three iron-sulfur clusters. The membrane anchoring proteins have 
2-3 subunits depending on the source of the complex. These proteins are generally 
referred to as QPs, cytochrome b56o, or hydrophobic protein fractions (9). 
Ubiquinol-cytochrome c reductase ( complex III or QCR) generates a proton 
gradient and membrane potential across the inner mitochondrial membrane for ATP 
synthesis. Its three redox centers, a Rieske high potential [2Fe-2S] cluster (22) and 
cytochromes band c1, are essential for QCR activity (23) . Succinate-Q reductase and 
QCR can be purified individually or co-purified as succinate cytochrome c reductase 
(SCR). There are two schools of thought regarding the physical state of succinate-Q 
reductase (SQR) and QCR in the mitochondrial inner membrane. Some evidence suggests 
that these reductases exist separately (85), while other evidence supports the existence of 
a SCR super-complex (86). 
In an effort to more clearly define the physical interactions between SQR and QCR 
and the action of NO on the electron transport pathway, we treated purified SCR. SQR, 
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and QCR with NO gas, individually and in combination. The results reported herein show 
that the effect of NO on SQR ranges from complete inhibition when SQR alone is treated, 
to a substantial activity loss (up to 95%) when SQR, as a component of SCR, is treated. 
EPR spectra confirm that these inhibitions are due to the destruction of iron sulfur 
clusters. Ubiquinol-cytochrome c reductase alone is partially susceptible to NO treatment 
but is not inactivated when it is in SCR. The protection of QCR from NO by SQR 
suggests that these two complexes may exist as a super-complex (86). 
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MATERIALS AND METHODS 
Materials- Purified SCR, SQR, and QCR were prepared by published procedures 
(87, 88). Succinate cytochrome c reductase was stored in 50 mM sodium/potassium 
phosphate buffer, pH 7.4, containing 0.25 M sucrose and 1 mM EDT A Succinate-Q 
reductase was stored in 0.2 M potassium phosphate buffer, pH 8.0, with 20 mM succinate, 
10% glycerol, and 0.2% sodium cholate. Ubiquinol-cytochrome c reductase was stored in 
50 mM Tris-Cl, pH 8.0, with 0.67 M sucrose. Succinate-Q reductas,e from E. coli was 
prepared by a previously reported method and stored in 20 mM Tris-Cl, pH 7.5, 
containing 2 mM phenylmethylsulfonyl fluoride, 100 mM NaCl and 0.2% Lubrol PX (52). 
For EPR measurements, glycerol was added to all samples to a final concentration of 
I 0%. Although each enzyme was stored and used in different buffers, optimal for their 
preservation, the type of storage buffer does not affect experimental results. To change 
buffers, the enzymes were precipitated with ammonium sulfate and redissolved in the 
desired buffer. 
Protein assays were according to Lowry (90), with crystalline bovine serum 
albumin as standard. Ubiquinone was measured spectrophotometrically in 95% ethanol 
using an extinction coefficient of 12.25 cm-1 mmor 1 Lat a Amax of278 for 2,3-
dimethoxy-3-methyl-6-( 1 O-bromo-decyl)-1,4-benzoquinone (QoC10Br). 
Spectrophotometric measurements were done on a Shimadzu UV-2101 PC 
spectrophotometer at room temperature. 
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Nitric oxide gas was obtained from Matheson Gas Products, Inc., and passed 
through sodium hydroxide pellets before use. Argon gas was from Sooner Airgas 
Inc.EPR spectra were obtained with a Bruker ER 200D spectrometer at 77 K. The details 
of the instrument settings are given in the figure legends. 
Assay Conditions- All enzyme activities were determined spectrophotometrically. 
Five µleach of 1 mg/ml SCR SQR, or 5 µl of 0.05 mg/ml QCR was used in a 1 ml assay 
mixture. Succinate-cytochrome c reductase was assayed in 100 mM sodium/potassium 
phosphate buffer, pH 7.4, containing 100 µM cytochrome c, 3 00 µM EDT A, and 20 mM 
succinate. The assay mixture for QCR contained the same phosphate buffer, at pH 7.0, 
without succinate, but with 25 nmol ofreduced QnC 10Br as substrate. For SCR and QCR, 
cytochrome c reduction was assayed at 550 nm using a millimolar extinction coefficient of 
18.5 cm-1 mmor1 L. Succinate-Q reductase assay mixture was 50 mM sodium/potassium 
phosphate buffer, pH 7.0, containing 50 µM 2,6-dichlorophenolindophenol (DCPIP), 100 
µM EDT A, and 20 mM succinate. 25 nmol QoC wBr was added as substrate and activities 
were measured by following the absorbance decrease at 600 nm as DCPIP was reduced, 
using a millimolar extinction coefficient of 21. 0 cm-1 mmor 1 L. 
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Nitric Oxide Treatment- Figure 8 diagrams the apparatus for treatment with NO 
and Scheme III outlines the procedure. All connections are either made of tygon or glass. 
Diluted (for activity assay) or undiluted (EPR spectra measurement) enzyme in a 
Thunberg tube at room temperature was stirred and flushed with argon gas for l min. The 
tube was then evacuated until the solution stopped bubbling. The argon and vacuum steps 
were repeated and argon was applied a third time for 2 min to remove oxygen. Vacuum 
was applied for a few seconds to empty the chamber, and discontinued as soon as bubbles 
appeared. The sample was then flushed with NO for l min with stirring and shaking to 
assure saturation. A 2 mM concentration of NO in the system was confirmed by titration 
of a buffer solution subjected to the same treatment. At the end of the reaction period, 
vacuum was applied briefly prior to flushing with argon to remove residual NO. It is 
important to note that although this procedure appears to be overly rigorous, these steps 
were necessary to assure that the enzyme did not denature due to pH changes caused by 
the reaction ofNO with oxygen. Specific activities of control samples, treated in the same 
manner, but without the NO step, remained unchanged. The concentration of protein 







Fig. 8 Nitric oxide reaction apparatus. 
Scheme III: Outline of Procedure for Treatment of Enzymes With 
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Effects of Nitric Oxide on Succinate Cytochrome c Reductase- The SCR 
preparation had about 4 nmol cytochrome b/mg protein and an activity of approximately 
1.5 µmol cytochrome c reduced min-1 mg-1 protein. The corresponding SQR and QCR 
activities were about 4 µmol DCPIP reduced min"1 mg-1 protein and 8 µmol cytochrome c 
reduced min-1 nmor1 cytochrome b, respectively, as components of SCR. After treatment 
of purified SCR with NO, the SCR, QCR, and SQR activities were assayed. Results are 
presented as percent of initial activity (Figure 9). 
As expected, the SQR component of SCR is very susceptible to NO. Nitric oxide 
treatment inhibits SQR activity up to a maximum of 95%, and the destruction of activity is 
irreversible. Conversely, QCR activity was only slightly affected by NO. The net effect of 
NO treatment on SCR was a 90% inhibition. NO inhibited all the complexes in a 
concentration dependent manner. The amount of SCR activity remaining correlated with 
the amount of SQR activity remaining. However, SQR was always more susceptible to 
NO than was SCR. This suggests that the site of action of NO on succinate cytochrome c 
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Fig 9. Effect of NO on the activities of succinate-cytochrome c reductase, ubiquinol-
cytochrome c reductase or succinate ubiquinone reductase. After purified 
succinate cytochrome c reductase, SCR (1 mg/ml), QCR (1 mg/ml), or SQR 
(1 mg/ml) were treated with NO, the activities of the enzymes were measured 
and the results presented as percent of initial activity. The darker bars 
represent succinate cytochrome c reductase treated with NO. The lighter bars 
represent purified QCR or SQR treated with NO. 
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Effects of Nitric Oxide on Purified Succinate-Ubiquinone Reductase and 
Ubiquinol-cytochrome c Reductase- The effects of NO on SQR and on QCR were also 
examined. The specific SQR activity averaged 12 µmol DCPIP reduced min-1 mi1 protein 
and QCR activity 8-10 µmol cytochrome c reduced rnin-1 nmor1 cyt b. When SQR was 
treated with NO gas for 1 min, almost all (>99%) activity was lost, compared to a 95% 
loss in the case of SCR. Succinate-Q reductase activity is completely abolished during 
prolonged incubation with NO. 
The effect of NO on QCR differs from its effect on QCR as a component of 
succinate cytochrome c reductase. Purified QCR is susceptible to NO treatment, losing 
40% of its activity during a 1 min incubation period. Longer incubation times result in 
little further activity loss. Most (96%) of the lost QCR activity is recovered, after NO 
removal, during a 24 hour incubation under air at O 0 C. In contrast, no SQR activity is 
restored under the same conditions. The greater susceptibility of isolated QCR to NO, 
compared to QCR in SCR, suggests some physical association between SQR and QCR. 
Perhaps SCR is a true physical entity, not simply a mixture of SQR and QCR. 
Activity Restoration of Nitric Oxide Treated Ubiquinol-Cytochrome c Reductase-
Figure 10 shows the 24 hour time course of activity restoration of NO treated QCR. 
Since the protocol for NO treatment calls for argon gas as a final step to displace residual 
NO, air was passed over the sample to remove the argon and to facilitate NO removal. 
The small jump in activity observed (Fig l 0) between the first and second points is the 
result of this additional step. Although most activity is regained during the first 12 hours 
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Fig 10. Time course of activity restoration of NO-treated ubiguinol-cytochrome c 
reductase. Purified QCR (0.07 mg/ml, 600 µM cyt b, in 50 mM Tris-Cl 
buffer, pH 8.0, containing 0.66 M sucrose) was treated with NO as described. 
After the initial activity loss was measured, air was passed over the sample for 
a period of 30 sec to remove argon gas from the Thunberg tube. Time zero 
represents the first measurement, made immediately after the argon was 
replaced by air. 
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of incubation, a recovery equal to 96% of initial activity is observed after 24 hours.; 
EPR Spectra of Succinate-Ubiquinone Reductase Before and After Nitric Oxide 
Treatment- Nitric oxide does not give an EPR signal at room temperature, or in the frozen 
state, for microwave frequencies from 9-35 GHz (82), but NO-iron complexes give very 
intense signals. Therefore, in an effort to characterize the effects of NO on the purified 
SQR and QCR complexes, EPR spectra of the complexes were obtained and compared. 
Concentrated samples of SQR (lOmg/mL) and QCR (14 mg/mL) were treated 
with NO gas and then reduced with sodium dithionite. EPR spectra were taken before 
and after treatment with NO. The spectra obtained from NO treated SQR corresponded 
to those previously reported (91). 
The EPR spectra of E. coli SQR (12 mg/mL) treated with NO, were obtained for 
comparison with the mitochondrial SQR spectra. Although the E. coli SQR spectra are 
somewhat different from those from mitochondrial SQR, due to inherently different 
properties of the two enzymes, the NO treated enzymes showed identical EPR spectra. 
Both the mitochondrial SQR and E. coli SQR spectra (Figure 11) have large 
shoulders/signals at g=2. 03 and g= 1. 93. However, the mitochondrial SQR spectrum has 
additional signals, missing in the E. coli SQR spectrum. The spectra of NO treated 
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Fig. 11 EPR spectra of purified mitochondrial and E. coli succinate-0 reductases. 
Purified mitochondrial SQR (10 mg/ml) (a) and E.coli SQR (12 mg/ml) (b) 
were reduced with dithionite and their EPR spectra measured. The instrument 
settings were as follows: microwave frequency, 9.29 GHz; microwave power, 
20 mW; modulation amplitude, 8 G; time constant, 0.5 s; temperature 77K 
and Gain 3.2 x 105. 
a 
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Fig. 12 EPR spectra of purified mitochondrial and E. coli succinate-0 reductases. 
Purified SQR (10 mg/ml) (a) and E. coli SQR (12 mg/ml) (b) were treated 
with NO, reduced with dithionite, and their EPR spectra measured. The 
instrument settings were as follows: microwave frequency, 9.29 GHz; 
microwave power, 20 mW; modulation amplitude, 8 G; time constant, 0.5 s; 
temperature 77K and Gain 3.2x104. 
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g=l.93. These are the well characterized NO-iron complex signals that appear when NO 
titrates iron in an iron-sulfur cluster (91 ). 
EPR Spectra ofUbiquinol-Cytochrome c Reductase Before and After Nitric Oxide 
Treatment- Figure 13 shows the EPR spectra of dithionite reduced native and NO treated 
QCR. The native enzyme shows a peak at g=2.0l, the Q radical signal, and another at 
g=l.90, the Rieske iron sulfur cluster signal. Although no NO-iron complex spectra 
appear, the Rieske iron sulfur signal disappears during NO treatment. After the 24 hour 
incubation period in the absence of NO, the Rieske iron-sulfur cluster EPR signal 
reappears. These data suggest two things. First, NO does not form a traditional NO-iron 
complex while inhibiting QCR activity. Second, this inhibition is clearly reversible. NO 
inhibition of QCR, which differs from the inhibition of SQR, is probably due to a 
conformational change caused by NO. Since no iron-NO spectra were observed and the 
loss of iron-sulfur cluster signal was reversible, the cluster was probably not totally 
destroyed. When denatured QCR is treated with NO, an NO-iron complex can be seen by 
EPR ( data not shown). This indicates that in the denatured enzyme the iron is titrated by 
NO, and supports the speculation that in fully active QCR, the loss of activity during NO 
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Fig. 13. EPR spectra of purified ubiquinol-cytochrome c reductase before and after 
treatment with NO and after a 24 hour incubation period of exposure to air. 
Purified QCR (14 mg/ml) was treated with NO as described above. The 
samples were divided into two portions. One (b) was immediately reduced 
with dithionite and frozen in liquid nitrogen. The other ( c) was incubated at 4 
~C, exposed to air for 24 hours, and then reduced with dithionite and frozen. 
Spectra (a) is an untreated control. The instrument settings were the same as 
those in Fig. 4. 
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DISCUSSION 
These experiments show that NO inhibits SQR ( complex II) by destroying iron-
sulfur clusters via formation of NO-iron complexes. More specifically, the target of action 
is succinate dehydrogenase (SDH), the subunit of SQR which contains iron-sulfur clusters. 
Although the precise configuration of the clusters in SDH is unknown, three clusters have 
been shown to exist. These are a [2Fe - 2S] (92), [3Fe - 3S or 4S] (8), and either [ 4Fe -
4S] or [2Fe - 2S] (93) type clusters. All or most of these clusters react with NO. The 
irreversible loss of activity in SQR is apparently due to the destruction of iron-sulfur 
clusters. Ubiquinol-cytochrome c reductase provides some protection against NO 
destruction of SQR. 
The mode of action of NO on free QCR is less clear. Although no specific NO-
iron complex is formed, NO inhibits QCR activity in a reversible manner. Since the 
activity loss in QCR is reversible, it is different from the irreversible loss of activity in 
SQR, in which the inhibition is entirely due to destruction of the iron-sulfur complexes. 
Although the site of NO action in QCR is not known, the disappearance of the 
EPR signal of the Rieske iron-sulfur center indicates that a change in structure occurred 
on or around this center. Probably NO affects the iron-sulfur center, without removing 
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iron from it, since NO has a high affinity for free iron and no NO-iron complex EPR signal 
is observed. The diminished effect of NO on QCR in SCR may be explained in at least 
two ways. First, the presence of SQR may prevent access of NO to the target site in 
QCR. Alternatively, the formation of a super-complex between SQR and QCR may 
render the latter resistant to a conformational change, which would have occurred in the 
absence of the former. These explanations are consistent with the speculation that SQR 
and QCR exist as a super-complex, in isolated preparations or in the inner mitochondrial 
membrane. 
Our results support earlier observations that NO affects different types of iron-
sulfur complexes in different ways ( 45). Conflicting results have shown NO to be an 
ineffective inhibitor of aconitase activity under anaerobic conditions (94, 95) and suggest 
that NO is only an intermediate on the way to more oxidizing compounds, such as 
peroxonitrite, the true inhibitor. It is unclear whether this is true for all enzymes with 
[ 4Fe-4s] iron-sulfur complexes or only for aconitase. Under the strict anaerobic 
conditions we adhered to during NO-treatment of our enzymes, no oxidants such as 
peroxonitrite will form. This implicates NO as the effector. To date, destruction of iron-
sulfur complexes by NO has been limited to enzymes which have the [4Fe-4S] type. 
Probably only certain types of clusters (e.g. ones where Fe is ligand to only one cysteinyl 
residue such as S2 and S3 of succinate dehydrogenase) are susceptible to NO titration, 
while others (such as the high potential Rieske [2Fe-2S] type, in which Fe is ligated to two 




Opening Remarks- The results reported in this thesis are the products of combined 
experiments designed to further elucidate the mechanisms of electron transport in 
cytochrome bo3 of E. coli and complexes II and III of beef heart mitochondria. In this 
work, "Studies of Electron Transport Complexes," two different approaches are taken to 
further investigate both the prokaryotic enzymes cytochrome bo3 and SQR from E. coli 
and SQR and QCR from beef heart mitochondria. Clear evidence for the site ofubiquinol 
binding being located on subunit II of cytochrome ho3 was demonstrated in chapter II with 
evidence based on the photoaffinity labeling by a substrate analog. These results had 
implications for both the system investigated, but also for all cytochrome oxidases of the 
heme-copper terminal oxidase superfamily. In the same spirit, chapter III examines the 
effects of nitric oxide on mitochondrial and bacterial preparations of complex II and 
mitochondrial preparations of complex III. The results demonstrate that the effects of NO 
on complex II are similar for beef heart preparations and E. coli preparations. Thus the 
investigations reported herein not only provide specific evidence of discovery, but they 
also help to further the understanding of electron transport complexes as a whole. 
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Identification of the Ubiquinol-Binding Site in the Cytochrome bo,-Ubiquinol 
Oxidase of Escherichia coli- In chapter II, a photoreactive radiolabeled azidoubiquinone 
derivative (azido-Q), was used to identify the subunit(s) involved in the binding of quinol 
to cytochrome bo3. Although the primary structures of all four subunits of this enzyme 
have been determined, the ubiquinol-binding site had not been investigated. Cytochrome 
bo3-ubiquinol oxidase is one of two ubiquinol oxidases in aerobic respiratory chain of 
Escherichia coli, and a member of the heme-copper oxidase superfamily. Our preparation 
showed four protein subunits (I-IV) with apparent molecular masses of 58, 33, 22, and 17 
kDa, respectively. The reaction catalyzed by cytochrome bo3 is the 2-electron oxidation 
of ubiquinol and the reduction of molecular oxygen to water. 
It was demonstrated that when azido-Q was reduced by dithioerythritol, the 
derivative functioned as a substrate with partial effectiveness. This suggested that azido-Q 
was indeed interacting with a legitimate quinol-binding site. When cytochrome ho_, was 
incubated with excess azido-Q, illumination by UV light for IO min resulted in a 50% loss 
of activity. The uptake of radiolabeled azido-Q by the oxidase complex upon illumination 
correlated with the photoinactivation. In the presence of the competitive inhibitor HQNO 
or QoC2, the rate of azido-Q uptake and loss of enzyme activity upon illumination 
decreased. Analysis of the distribution of radioactivity among the subunits after separation 
by SDS-poyacrylamide gel electrophoresis showed that subunit II was heavily labeled by 
azido-Q, but that the other subunits were not. This evidence suggested that the ubiquinol-
binding site is located at least partially on subunit II. 
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Future Experiments on Cytochrome bo3 of Escherichia coli- With molecular 
genetics in E. coli routine, and the bacterial oxidase operon cloned (96, 97) and expressed 
(98, 99), several labs are conducting studies on cytochrome bo3, using it as the model 
system of the heme-copper respiratory oxidases. The aim is to use molecular genetic 
manipulation coupled with biophysical approaches to identify key residues which are 
involved in either electron transfer substrate binding, ligation of metal ions, or proton 
translocation. Since evidence now points to subunit II as the probable location of quinol 
binding, and subunit I is known to contain all the metal centers, most research will focus 
on these two subunits. Indeed it appears that subunits I and II, coded by cyoA and B, 
form a functional core for cytochrome bo3, analogous to what has been observed in other 
heme-copper oxidases namely cytochrome c oxidase. 
Concerning the quinol binding site on subunit II, there is much to be learned. 
Foremost is the determining the peptide sequence to which ubiquinol-8 has affinity. This 
can be best accomplished by techniques similar to those presented in this work. By using 
an azido-Q photoaffinity label and HPLC to separate digested protein fragments, labeled 
peptide fragments can be detected and their amino acid sequence determined. However, 
cytochrome bo3 is a membrane bound protein and relatively hydrophobic making this 
procedure timely and difficult. Other investigations will focus on the tertiary structure of 
the quinone binding pocket, and how electrons are transferred to the first redox center in 
subunit I. 
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Simultaneous studies on complex I revolved around the molecular structure of the 
metal redox centers, and their three-dimensional arrangement. The use of many 
spectroscopic and biophysical approaches has revealed much about the arrangements of 
these centers and has led to the formulation of some structural models, but this runs 
beyond the scope of this paper (for review see 100). Of course all three-dimensional 
models will ultimately be tested against X-ray crystallographic studies and crystallization 
of the complex will be a priority until defractable crystals are obtained. 
The Effects of Nitric Oxide on Electron Transport Complexes- In chapter III, the 
effects of nitric oxide on mitochondrial electron transfer complexes were studied by 
comparing the activities of nitric oxide treated and untreated, deoxygenated samples of 
purified beef heart succinate-cytochrome c reductase, succinate-ubiquinone reductase, and 
ubiquinol-cytochrome c reductase. Also investigated were the effects of nitric oxide on E. 
coli succinate-Q reductase. Both mitochondrial and E. coli succinate-Q reductase 
demonstrated the same reaction with nitric oxide, that is irreversible total activity loss due 
to the titration of their iron-sulfur clusters. 
However when mitochondrial succinate cytochrome c reductase was treated with 
nitric oxide only 90% of succinate-Q reductase activity is lost and the ubiquinol-
cytochrome c reductase component appeared to be unaffected. When purified 
mitochondrial ubiquinol-cytochrome c reductase was treated with nitric oxide, it lost 40% 
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of its initial activity, but recovered most of it (90-100%) after an incubation period in the 
absence of nitric oxide. The loss ofubiquinol-cytochrome c reductase activity correlated 
with a decrease in the Rieske protein EPR signal intensity without formation of any new 
EPR signal, but the original signal was recovered after the incubation period. The fact 
that ubiquinone-cytochrome c reductase was protected from nitric oxide in the presence of 
copurified succinate-Q reductase suggested a specific interaction between the two 
complexes. In addition, the possibility that nitric oxide effects different iron sulfur clusters 
in different ways was discussed based on the results which showed reversible activity loss 
for the Rieske center. 
Future Experiments on the Effects of Nitric Oxide on Electron Transport 
Complexes- We proposed two explanations as to why the effects of NO on QCR in SCR 
are diminished compared to SQR in SCR. First was the possibility that access of NO to 
the target site in QCR may be prevented by SQR. The other explanation was that a super-
complex of SQR and QCR could make QCR resistant to conformational changes which 
might occur in the absence or SQR, and in this way prevent NO inactivation. Either 
proposal supports the speculation that SQR and QCR naturally assume a super-complex 
formation in the mitochondria, or as SCR preparations. Further experimentation using 
biophysical techniques will be aimed at further defining the interactions of SQR and QCR 
in the presence and absence of nitric oxide. 
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The second major finding of our experiments centered around the manner in which 
NO effected the Rieske [2Fe-2S] iron sulfur cluster. Prior to this work, only enzymes of 
the [ 4Fe-4S) type clusters have shown NO inactivation. This raises the question as to 
whether or not NO has preference to different types of iron sulfur clusters. Are only 
certain types of clusters vulnerable to NO attack? This question has profound medical 
importance since many cells of the immune response including macrophages and 
neutrophils release NO as a destructive compound of attack. Curiously, some cells (such 
as rnicroglia cells and other NO producing cells) are better at fending off macrophage 
derived NO than others (101). Some bacteria are also resistant. Perhaps some cells 
resistant to immune attack do not rely on [ 4Fe-4S] clusters for respiration or have other 
mechanisms of evasion .. Future experiments will therefore be aimed at the effects of NO 
on respiratory enzymes with non [ 4Fe-4S] clusters. Since the Rieske subunit of 
Rhodobacter sphaeroides can be expressed in E. coli in the absence of other subunits 
(102), this protein may prove of great interest in further defining these mechanisms. 
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